Galera Therapeutics, INC. (GRTX) — SC 13D/A Filings
All SC 13D/A filings from Galera Therapeutics, INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Sofinnova Amends Galera Therapeutics Stake
— Feb 20, 2024 Risk: medium
Sofinnova Venture Partners IX, L.P. and its affiliates, including Sofinnova Management IX, L.L.C. and Dr. James I. Healy, filed an Amendment No. 2 to their Sche
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX